UCLA and Parker Institute renew alliance to advance cancer immunotherapy

UCLA and the Parker Institute for Cancer Immunotherapy (PICI) have renewed their alliance to advance research in cancer immunotherapy and accelerate the development of curative treatments for the most difficult-to-treat cancers.

Mid-Stage Win for Novel IgA Nephropathy Drug

PHILADELPHIA — An investigational humanized IgG2 monoclonal antibody reduced proteinuria in adults with immunoglobulin A (IgA) nephropathy at high risk for disease progression despite standard

November 3, 2023

Osteoarthritis linked to accelerated progression of severe long-term conditions

Osteoarthritis-;a condition in which the protective cartilage on the ends of bones breaks down-;may more than double the risk of speedy progression to accumulating severe

July 10, 2024

I’m a geriatrician. Improv is one of my favorite tools for working with dementia patients

My cousin and I were signing my aunt out of the memory care facility to go into town for breakfast. When the aide at the

March 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.